FP7
PHARMA-COG
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical development
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 30,715,556
- EU contribution
- EUR 9,658,388
- Participants
- 36 from 12 countries
- Topic
- FP7_IMI-JU-01-2008-11
- Grant agreement
- 115009
Coordinated by Glaxosmithkline Research & Development Limited (GBUnited Kingdom).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Coordinator | Not stated | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | Not stated | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| Universitaet Leipzig | DEGermany | Participant | EUR 176,715 | PIC (1.00) |
| Universitaetsklinikum Essen | DEGermany | Participant | EUR 70,748 | PIC (1.00) |
| H. Lundbeck As | DKDenmark | Participant | Not stated | PIC (1.00) |
| Consorci Institut D'Investigacions Biomediques August Pi i Sunyer | ESSpain | Participant | EUR 560,973 | known name (0.95) |
| Universidad de Murcia | ESSpain | Participant | EUR 300,000 | known name (0.95) |
| Centre National de la Recherche Scientifique Cnrs | FRFrance | Participant | EUR 205,000 | known name (0.95) |
| Diaxonhit SA | FRFrance | Participant | EUR 259,677 | PIC (1.00) |
| Innovative Concepts in Drug Development (ICDD-sas) | FRFrance | Participant | EUR 298,423 | PIC (1.00) |
| Innovative Health Diagnostics | FRFrance | Participant | EUR 121,100 | PIC (1.00) |
| Institut de Recherches Servier | FRFrance | Participant | Not stated | PIC (1.00) |
| Institut National de la Sante et de la Recherche Medicale | FRFrance | Participant | EUR 1,010,591 | known name (0.95) |
| Qualissima | FRFrance | Participant | EUR 544,752 | PIC (1.00) |
| SAS Alzprotect | FRFrance | Participant | EUR 304,377 | PIC (1.00) |
| Universite D'Aix Marseille | FRFrance | Participant | EUR 1,658,892 | known name (0.95) |
| Université Lille 2 Droit et Santé | FRFrance | Participant | EUR 1,066,828 | PIC (1.00) |
| Eisai Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| The University of Exeter | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| University of Bristol | GBUnited Kingdom | Participant | Not stated | known name (0.95) |
| Elliniki Etairia Nosoy Alzheimer Kai Syggenon Diatarachon Somateio | GRGreece | Participant | EUR 205,519 | PIC (1.00) |
| Irccs Fondazione Sdn Per la Ricerca e L'Alta Formazione in Diagnostica Nucleare | ITItaly | Participant | EUR 62,393 | PIC (1.00) |
| Istituto di Ricerche Farmacologiche Mario Negri | ITItaly | Participant | EUR 549,000 | PIC (1.00) |
| Provincia Lombardo Veneta - Ordineospedaliero di San Giovanni di Dio- Fatebenefratelli | ITItaly | Participant | EUR 767,507 | PIC (1.00) |
| Universita Cattolica del Sacro Cuore | ITItaly | Participant | EUR 62,400 | known name (0.95) |
| Universita Degli Studi di Foggia | ITItaly | Participant | EUR 448,496 | known name (0.95) |
| Universita Degli Studi di Genova | ITItaly | Participant | EUR 176,597 | known name (0.95) |
| Universita Degli Studi di Perugia | ITItaly | Participant | EUR 304,400 | known name (0.95) |
| Universita Degli Studi di Verona | ITItaly | Participant | EUR 360,000 | known name (0.95) |
| Alzheimer Europe | LULuxembourg | Participant | EUR 100,000 | PIC (1.00) |
| Stichting Vu | NLNetherlands | Participant | EUR 44,000 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 36 participants from 12 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.